Biomedical Engineering Reference
In-Depth Information
Choudhry NK, Stelfox HT, Detsky AS (2002) Relationships between authors of clinical practice
guidelines and the pharmaceutical industry. J Am Med Assoc 287(5):612-617
Collis D, Smith T (2007) Strategy in the twenty-fi rst century pharmaceutical industry: Merck &
Co. and Pfi zer, Inc. Harvard Business School 707(509):1-37
Croasdale M (2006) Some Medical Schools Say No to Drug Reps' Free Lunch. www.amednews.
com/article/20061009/profession/310099967/2/ . Accessed Aug 31, 2007
Datamonitor (2001) Personalized physician marketing: using physician profi ling to maximize
returns. Datamonitor, New York
Datamonitor (2006) Pharmaceuticals in the United States: industry profi le. Datamonitor, New York
DeAngelis
CD
(2006)
The
infl uence of money on medical science. J Am Med Assoc
296(2):996-998
Deephouse DL, Carter SM (2005) An examination of differences between organizational legiti-
macy and organizational reputation. J Manage Stud 42:329-360
Denzau AT, North DC (1994) Shared mental models: ideologies and institutions. Kyklos
47(1):3-35
DiMaggio PJ (1997) Culture and cognition: an interdisciplinary review. Ann Rev Sociol
23:263-287
DiMaggio PJ, Powell WW (1983) The iron cage revisited: institutional isomorphism and collective
rationality in organizational fi elds. Am Sociol Rev 48:147-160
DiMaggio PJ, Powell WW (1991) Introduction. In: Powell WW, DiMaggio PJ (eds) The new
institutionalism in organizational analysis. University of Chicago Press, Chicago, pp 1-38
Eichacker PQ, Natanson C, Danner RL (2006) Surviving sepsis: practice guidelines, marketing
campaigns, and Eli Lilly. N Engl J Med 355:1640-1642
Esch M. (2008) Legal questions raised on NY's gas-drilling rules. http://hosted2.ap.org/PASCR/
d30f3f32e9d849979111e891380b64db/Article_2011-07-11-Gas%20Drilling-NY%20Rules/
id-a10f25d5982b48fa979fea01a1e020ff . MARY ESCH. Accessed July 15, 2011
Fagan P, Hayes R. (1998) Pharma Giants: Ready for the 21st Century? Harvard Business School
Cases [serial online]. Available from: Business Source Complete, Ipswich, MA. Accessed Jun
17, 2013
Flanagin A, Carey LA, Fontanarosa PB, Phillips SG, Pace BF, Lundberg GD, Rennie D (1998)
Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical jour-
nals. J Am Med Assoc 280(3):222-224
Freidson E (2001) Professionalism: the third logic. University of Chicago Press, Chicago
Fugh-Berman A (2008) Prescription tracking and public health. J Gen Intern Med
23(8):1277-1280
Gagnon M-A, Lexchin J (2008) The cost of pushing pills: a new estimate of pharmaceutical pro-
motion expenditures in the United States. PLoS Med 5(1)
George E, Chattopadhaya P, Sitkin SB, Barden J (2006) Cognitive underpinnings of institutional
persistence and change: a framing perspective. Acad Manage Rev 31(2):347-365
Giddens A (1990) The consequences of modernity. Polity Press, Cambridge
Gönül FF, Carter F, Petrova E, Srinivasan K (2001) Promotion of prescription drugs and its impact
on physicians' choice behavior. J Market 65(3):79-90
Grande D (2007) Prescriber profi ling: time to call It quits. Ann Intern Med 146:751-752
Grayson K, Johnson D, Chen D-FR (2008) Is fi rm trust essential in a trusted environment? How
trust in the business context infl uences customers. J Market Res 45(April):241-256
Greene J (2007) Pharmaceutical marketing research and the prescribing physician. Ann Intern
Med 146:742-748
Grewal R, Dharwadkar R (2002) The role of the institutional environment in marketing channels.
J Market 66(3):82-97
Health Committee (2005) The infl uence of the pharmaceutical industry. http://www.parliament.
the-stationery-offi ce.co.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf . Accessed Jan 31, 2007
Healy D, Cattell D (2003) Interface between authorship, industry and science in the domain of
therapeutics. Br J Psychiatry 183:22-27
Search WWH ::




Custom Search